Publication | Closed Access

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study†

Gastrointestinal OncologyMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerPharmacotherapyMolecular OncologyCancer TreatmentExtended PhaseFirst-line ChemotherapyOncologyRadiation OncologyCancer Research